Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2141-V11 in Bladder Cancer
NCT05126472Phase 2Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2021
- Primary completion
- Nov 2027
- Modality
- Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 2141-V11 in non-muscle-invasive bladder cancer (NMIBC), sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 2021; status: recruiting.
02
Drugs
2141-V11
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT05126472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05126472.